[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CA2116334A1 - Antagoniste de l'oxytocine - Google Patents

Antagoniste de l'oxytocine

Info

Publication number
CA2116334A1
CA2116334A1 CA 2116334 CA2116334A CA2116334A1 CA 2116334 A1 CA2116334 A1 CA 2116334A1 CA 2116334 CA2116334 CA 2116334 CA 2116334 A CA2116334 A CA 2116334A CA 2116334 A1 CA2116334 A1 CA 2116334A1
Authority
CA
Canada
Prior art keywords
optionally
substituted
alkyl
alkoxy
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2116334
Other languages
English (en)
Inventor
Hidenori Ogawa
Hisashi Miyamoto
Kazumi Kondo
Hiroshi Yamashita
Kenji Nakaya
Michinori Tanaka
Kazuyoshi Kitano
Keizo Kan
Michiaki Tominaga
Yoichi Yabuuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2116334A1 publication Critical patent/CA2116334A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA 2116334 1992-07-02 1993-06-22 Antagoniste de l'oxytocine Abandoned CA2116334A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP17556692 1992-07-02
JP17556392 1992-07-02
JP175566/1992 1992-07-02
JP175563/1992 1992-07-02

Publications (1)

Publication Number Publication Date
CA2116334A1 true CA2116334A1 (fr) 1994-01-20

Family

ID=26496804

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2116334 Abandoned CA2116334A1 (fr) 1992-07-02 1993-06-22 Antagoniste de l'oxytocine

Country Status (8)

Country Link
EP (1) EP0602209A1 (fr)
CN (1) CN1091288A (fr)
AU (1) AU657424B2 (fr)
CA (1) CA2116334A1 (fr)
ID (1) ID15999A (fr)
MX (1) MX9304015A (fr)
TW (1) TW249201B (fr)
WO (1) WO1994001113A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356904A (en) * 1992-10-07 1994-10-18 Merck & Co., Inc. Carbostyril oxytocin receptor antagonists
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
CA2166975C (fr) * 1993-07-16 2005-04-05 Mark G. Bock Derives de la benzoxazinone et de la benzopyrimidinone, antagonistes des recepteurs de l'oxytocine et de la vasopressine
WO1996022775A1 (fr) * 1995-01-24 1996-08-01 Merck & Co., Inc. Antagonistes tocolytiques des recepteurs de l'oxytocine
TW359669B (en) * 1995-12-15 1999-06-01 Otsuka Pharma Co Ltd Benzazepine derivatives
US5726172A (en) * 1996-01-16 1998-03-10 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
AR011913A1 (es) 1997-03-06 2000-09-13 Yamano Masaki Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
US6977254B2 (en) 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7202239B2 (en) 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7064120B2 (en) 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7326700B2 (en) 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
GB0120051D0 (en) * 2001-08-16 2001-10-10 Ferring Bv Oxytocin agonists
US20050228016A1 (en) * 2002-06-13 2005-10-13 Enrique Michelotti Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
CN1681487A (zh) 2002-07-15 2005-10-12 美瑞德生物工程公司 化合物、组合物及其使用方法
US7504508B2 (en) 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
BR0315041A (pt) 2002-10-04 2005-08-16 Millennium Pharm Inc Métodos para inibir crth2 em um indivìduo que necessita inibição de crth2; composto; e composição farmacêutica
JP2006512404A (ja) * 2002-10-22 2006-04-13 グラクソ　グループ　リミテッド Ｈ３受容体リガンドとしてのアリールオキシアルキルアミン誘導体
TW200503994A (en) * 2003-01-24 2005-02-01 Novartis Ag Organic compounds
TWI322689B (en) 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
KR20070114762A (ko) 2005-02-24 2007-12-04 밀레니엄 파머슈티컬스 인코퍼레이티드 염증 질환 치료를 위한 ｐｇｄ2 수용체 길항제
US7671058B2 (en) 2006-06-21 2010-03-02 Institute Of Medicinal Molecular Design, Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives
EA017249B8 (ru) 2007-05-10 2013-01-30 Олбани Молекьюлар Рисерч, Инк. Арил- и гетероарилзамещенные тетрагидробензо-1,4-диазепины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
TWI459947B (zh) * 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑
CN102030709B (zh) * 2009-09-25 2013-10-16 江苏豪森医药集团有限公司 用作加压素受体拮抗剂的苯并氮杂卓类化合物
US9238658B2 (en) 2011-12-06 2016-01-19 Janssen Pharmaceutica Nv Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors
US9102669B2 (en) 2011-12-06 2015-08-11 Janssen Pharmaceutica Nv Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors
WO2017156164A1 (fr) 2016-03-09 2017-09-14 Board Of Regents, The University Of Texas System Antagonistes du récepteur de 20-hete (gpr75) et procédés d'utilisation
WO2019003433A1 (fr) 2017-06-30 2019-01-03 大塚製薬株式会社 Dérivé de benzazépine
TW202016094A (zh) * 2018-06-29 2020-05-01 美商奇奈特生物製藥公司 週期素依賴性激酶抑制劑
EP4253367A4 (fr) * 2020-11-26 2024-10-23 Shanghai Jemincare Pharmaceuticals Co Ltd Nouveau dérivé spiro de benzazépine
CN112851583B (zh) * 2021-01-19 2023-09-08 徐州医科大学 新型苯并氮杂䓬类化合物、组合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69009785T2 (de) * 1989-02-10 1994-11-03 Otsuka Pharma Co Ltd Carbostyrilderivate.
CA2026856A1 (fr) * 1989-10-05 1991-04-06 Mark G. Bock Derives de substitution en 3 de 1,4-benzodiazepines, utiles comme oxytocine
ES2089033T3 (es) * 1989-10-20 1996-10-01 Otsuka Pharma Co Ltd Compuestos benzoheterociclicos.
TW199153B (fr) * 1990-08-07 1993-02-01 Dtsuka Seiyaku Kk

Also Published As

Publication number Publication date
TW249201B (fr) 1995-06-11
EP0602209A1 (fr) 1994-06-22
AU4356993A (en) 1994-01-31
AU657424B2 (en) 1995-03-09
MX9304015A (es) 1994-02-28
CN1091288A (zh) 1994-08-31
ID15999A (id) 1997-08-21
WO1994001113A1 (fr) 1994-01-20

Similar Documents

Publication Publication Date Title
CA2116334A1 (fr) Antagoniste de l'oxytocine
TWI327570B (en) Fused azole-pyrimidine derivatives
AU2007269070B2 (en) Bicyclic heteroaryl inhibitors of PDE4
JP7203752B2 (ja) デングウイルス複製阻害剤としての置換インドリン誘導体
WO2005080399A1 (fr) Composés hétérotétracycliques fondus et utilisation de ces composés en tant qu'inhibiteurs par polymérase du virus de l’hépatite c
TWI771420B (zh) 作為登革熱病毒複製抑制劑之經取代之吲哚啉衍生物（一）
CZ161993A3 (en) Peptides capable of inhibiting activity of hiv protease, their preparation and therapeutic use
AU2009799A (en) 4-(aryl(piperidin-4-yl)) aminobenzamides which bind to the delta-opioid receptor
AU2016202949A1 (en) Novel nicotinamide derivative or salt thereof
WO2001021169A1 (fr) Antagonistes de l'hormone de concentration de la melanine
CN108430994A (zh) 用于调节cftr的化合物、组合物和方法
CN102532162A (zh) 2,3-二氢-6-硝基咪唑并[2,1-b]噁唑化合物
WO2001047883A1 (fr) Composes a cycles accoles et leur utilisation comme medicaments
JPH09505036A (ja) 喘息治療用のニューロキニン２受容体拮抗薬としての新規な４−ピペリジニル置換ラクタム
US20040068109A1 (en) Diazepan derivatives or salts thereof
JP2004517072A (ja) Ｃｎｓ障害の治療において有用な化合物
WO2005087729A1 (fr) Derives de 5-hydroxyindol-3-carboxylate et leur utilisation
WO2008138448A2 (fr) Dérivés d'indazole hétérocycliques
EP2003131A1 (fr) Composé d'aminopyrrolidine
CA2770767A1 (fr) Inhibiteurs de la pde4 de type heteroaryle bicyclique
EP1928460A2 (fr) Nouvelles utilisations de composes d'agonistes du recepteur de mc4
EP0694536A1 (fr) Dérivés de 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one, leur préparation, et compositions pharmaceutiques les contenant
WO2006057270A1 (fr) Composé tricyclique azoté
EP3190111B1 (fr) Dérivés de pyrazolo[3,4-c]pyridine
WO2019185046A1 (fr) Composé de lactame quaternaire et son utilisation pharmaceutique

Legal Events

Date Code Title Description
FZDE Dead